{"product_id":"infostretch-pharmaceuticals-life-sciences-operational-transformation","title":"Infostretch - Pharmaceuticals \/ Life Sciences Operational Transformation","description":"\u003cp\u003eInfostretch - Pharmaceuticals \/ Life Sciences Operational Transformation\u003c\/p\u003e\n\n\u003cp\u003eWho is This Vendor Assessment For?\u003c\/p\u003e\n\n\u003cp\u003eNelsonHall’s pharmaceuticals \/ life sciences operational transformation profile on Infostretch is a comprehensive assessment of Infostretch’s offerings and capabilities, designed for:\u003cbr\u003e\nSourcing managers monitoring the capabilities of existing suppliers of pharmaceuticals \/ life sciences operational transformation services and identifying vendor suitability for operational transformation services RFPs\u003cbr\u003e\nVendor marketing, sales, and business managers looking to benchmark themselves against their peers\u003cbr\u003e\nFinancial analysts and investors specializing in the pharmaceuticals \/ life sciences services sector.\u003c\/p\u003e\n\n\u003cp\u003eKey Findings \u0026amp; Highlights\u003c\/p\u003e\n\n\u003cp\u003eInfostretch is a pure-play digital engineering services firm focusing on digital transformation, particularly in financial services and healthcare\/life sciences sectors. In August 2020, it received a private equity investment from Goldman Sachs and Everstone group. Infostretch is the digital engineering services platform for the Goldman Sachs portfolio. Following the investment, Infostretch has acquired Saggezza (March 2021), digital technology and consulting firm, and Gathi Analytics (August 2021), a data analytics firm.\u003c\/p\u003e\n\n\u003cp\u003eScope of the Report\u003c\/p\u003e\n\n\u003cp\u003eThe report provides a comprehensive and objective analysis of Infostretch’s pharmaceuticals \/ life sciences operational transformation offerings and capabilities, and market and financial strengths, including:\u003cbr\u003e\nIdentification of the company’s strategy, emphasis, and new developments\u003cbr\u003e\nAnalysis of the company’s strengths, weaknesses, and outlook\u003cbr\u003e\nRevenue estimates\u003cbr\u003e\nAnalysis of the profile of the company’s customer base, including the company’s targeting strategy and examples of current contracts\u003cbr\u003e\nAnalysis of the company’s offerings and key service components\u003cbr\u003e\nAnalysis of the company’s delivery organization, including the location of delivery locations.\u003c\/p\u003e","brand":"Technology \u0026 Media","offers":[{"title":"October, 2021 \/ 11 Pages \/ MCW16285012","offer_id":47714864791858,"sku":null,"price":2160.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/infostretch-pharmaceuticals-life-sciences-operational-transformation","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}